F/m Emerald Life Sciences Innovation ETF (LFSC)
38.07
-0.80
(-2.06%)
USD |
NASDAQ |
Dec 29, 16:00
38.23
+0.16
(+0.41%)
After-Hours: 20:00
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.54% | -0.02% | 98.64M | 7782.67 |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 0.00% | 19.00% | 10.53M | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term capital appreciation. The Fund is an actively managed exchange-traded fund (ETF) and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust (the Sub-Adviser), the Funds investment sub-adviser, under the supervision of the Adviser. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Small Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | F/m Investments |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of December 30, 2025.
Asset Allocation
As of November 30, 2025.
| Type | % Net |
|---|---|
| Cash | -1.21% |
| Stock | 98.01% |
| Bond | 2.01% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 1.18% |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term capital appreciation. The Fund is an actively managed exchange-traded fund (ETF) and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust (the Sub-Adviser), the Funds investment sub-adviser, under the supervision of the Adviser. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Small Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | F/m Investments |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |